Caplin Point Laboratories Ltd Half Yearly Results

Gross Sales

995.41

942.06

888.72

805.38

761.35

Excise Duty

0

0

0

0

0

Net Sales

995.41

942.06

888.72

805.38

761.35

Other Operating Income

0

0

0

0

0

Other Income

57.1

39.33

34.55

32.66

25.64

Total Income

1,052.51

981.39

923.27

838.04

786.99

Total Expenditure

664.98

625.57

601.21

541.45

528.04

PBIDT

387.53

355.82

322.06

296.59

258.95

Interest

0.35

0.26

0.32

0.46

0.58

PBDT

387.18

355.56

321.74

296.13

258.37

Depreciation

33.24

32.72

30.3

23.14

22.56

Minority Interest Before NP

0

0

0

0

0

Tax

63.49

61.84

46.58

54.97

42.42

Deferred Tax

5.09

5.27

3.81

-2.35

-5.26

Reported Profit After Tax

285.36

255.73

241.05

220.37

198.65

Minority Interest After NP

3.82

0.96

2.26

2.07

-0.95

Net Profit after Minority Interest

281.54

254.77

238.79

218.3

199.6

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

281.54

254.77

238.79

218.3

199.6

EPS (Unit Curr.)

37.04

33.54

31.44

28.75

26.3

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

100

0

Equity

15.2

15.2

15.19

15.19

15.18

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

38.93

37.77

36.23

36.82

34.01

PBDTM(%)

-

-

-

-

-

PATM(%)

28.66

27.14

27.12

27.36

26.09